Metabolic Syndrome and Metabolic Dysfunction-associated Steatotic Liver Disease in Fibromyalgia
Fibromyalgia patients had a higher proportion of central adiposity and more severe hepatic steatosis when compared with the controls. Those patients with more severe FM symptoms likely had a higher cardiovascular risk. Metabolic dysfunction-associated steatotic liver disease merits more attention in FM patients. Cite this article as: Chen C, Chen Y, Chen D, Yang S, Tang K. Metabolic syndrome and metabolic dysfunction-associated steatotic liver disease in fibromyalgia. Arch Rheumatol. 2025;40(4):452-458.
Authors
- Chia‐Chang Chen (ORCID: https://orcid.org/0000-0002-4407-2052)
- Kuo‐Tung Tang (ORCID: https://orcid.org/0000-0002-5468-1329)
- Sheng‐Shun Yang
- Yi‐Hsing Chen (ORCID: https://orcid.org/0000-0002-8135-9554)
- Der‐Yuan Chen (ORCID: https://orcid.org/0000-0003-1266-1423)
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Taichung Veterans General Hospital (TW)
- National Taipei University (TW)
Publication Details
- Journal
- Archives of Rheumatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.5152/archrheumatol.2025.25004
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taichung Veterans General Hospital